Key result
Identifying high-risk atrial fibrillation patients using novel tools like natriuretic peptides should become a cornerstone of management to reduce mortality and heart failure.
Highlights the need for improved risk stratification in atrial fibrillation using biomarkers like natriuretic peptides to identify patients at high risk for heart failure and death.
No takes yet. Share an insight, caveat, or question.
Eduard Guasch (2021) conducted an editorial in Atrial fibrillation. Identifying high-risk atrial fibrillation patients using novel tools like natriuretic peptides should become a cornerstone of management to reduce mortality and heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: